{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:04:01Z","timestamp":1758053041346,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.crad.2018.03.018","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T05:12:22Z","timestamp":1525065142000},"page":"632-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic performance of a streamlined 18F-choline PET-CT protocol for the detection of prostate carcinoma recurrence in combination with appropriate-use criteria"],"prefix":"10.1016","volume":"73","author":[{"given":"R.","family":"Frood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Baren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bottomley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Scarsbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.crad.2018.03.018_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","article-title":"Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience","volume":"28","author":"Han","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.crad.2018.03.018_bib2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.09.039","article-title":"Utility of choline positron emission tomography\/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis","volume":"63","author":"Evangelista","year":"2013","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.crad.2018.03.018_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.crad.2017.02.010","article-title":"Prostate cancer: state of the art imaging and focal treatment","volume":"72","author":"Woodrum","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2018.03.018_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part 2: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Mottet","year":"2014","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.crad.2018.03.018_bib5","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.crad.2016.05.001","article-title":"Evidence-based indications for the use of PET-CT in the United Kingdom 2016","volume":"71","author":"Royal College of Radiologists","year":"2016","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.crad.2018.03.018_bib6","first-page":"187","article-title":"Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging","volume":"43","author":"Hara","year":"2002","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.crad.2018.03.018_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-5347(05)64906-3","article-title":"Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer","volume":"168","author":"Price","year":"2002","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.crad.2018.03.018_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nucmedbio.2006.08.002","article-title":"Effect of hypoxia on the uptake of [methyl-3H]choline, [1\u201314C] acetate and [18F]FDG in cultured prostate cancer cells","volume":"33","author":"Hara","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.crad.2018.03.018_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000019923","article-title":"Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy","volume":"36","author":"Hofer","year":"1999","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.crad.2018.03.018_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.crad.2018.03.018_bib11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-Choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2018.03.018_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2967\/jnumed.112.110148","article-title":"Impact of 18F-Choline PET\/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics","volume":"54","author":"Beheshti","year":"2013","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.crad.2018.03.018_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2967\/jnumed.114.141887","article-title":"Gleason score at diagnosis predicts the rate of detection of 18F-choline PET\/CT preformed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients","volume":"56","author":"Cimitan","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2018.03.018_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3413\/nukmed-0194","article-title":"Three-phase 18F fluorocholine PET\/CT in the evaluation of prostate cancer recurrence","volume":"48","author":"Steiner","year":"2009","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.crad.2018.03.018_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2967\/jnumed.112.110148","article-title":"Impact of 18F-choline PET\/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics","volume":"54","author":"Beheshti","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2018.03.018_bib16","first-page":"1805","article-title":"Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers","volume":"42","author":"DeGrado","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2018.03.018_bib17","first-page":"50","article-title":"Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging","volume":"52","author":"Kumar","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.crad.2018.03.018_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET\/CT","volume":"44","author":"Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2018.03.018_bib19","article-title":"68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis","author":"von Eyben","year":"2016","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.crad.2018.03.018_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"RadioGraphics"},{"issue":"12","key":"10.1016\/j.crad.2018.03.018_bib21","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","author":"Schuster","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2018.03.018_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-015-3202-7","article-title":"PET\/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data","volume":"43","author":"Fanti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.crad.2018.03.018_bib23","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00259-010-1403-7","article-title":"PSA doubling time for prediction of [(11)C]choline PET\/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.crad.2018.03.018_bib24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00259-015-3306-0","article-title":"PET\/CT with (18)F-choline after radical prostatectomy in patients with PSA \u22642 ng\/ml. Can PSA velocity and PSA doubling time help in patient selection?","volume":"43","author":"Chiaravalloti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.crad.2018.03.018_bib25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00345-015-1481-z","article-title":"Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with 1\u2078F-fluorocholine positron emission tomography\/computed tomography","volume":"33","author":"Simone","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.crad.2018.03.018_bib26","doi-asserted-by":"crossref","first-page":"215650","DOI":"10.1155\/2014\/215650","article-title":"New acquisition protocol of 18F-choline PET\/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization","volume":"2014","author":"Chondrogiannis","year":"2014","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.crad.2018.03.018_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","article-title":"Role of whole-body 18F-choline PET\/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol Med"},{"issue":"2","key":"10.1016\/j.crad.2018.03.018_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00259-011-1970-2","article-title":"Relationship between PSA kinetics and [18F]fluorocholine PET\/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy","volume":"39","author":"Graute","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.crad.2018.03.018_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000001197","article-title":"68Ga-PSMA-PET\/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET\/CT","volume":"41","author":"Bluemel","year":"2016","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018301399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018301399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:36:54Z","timestamp":1757867814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926018301399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0009926018301399"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2018.03.018","relation":{},"ISSN":["0009-9260"],"issn-type":[{"type":"print","value":"0009-9260"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of a streamlined 18F-choline PET-CT protocol for the detection of prostate carcinoma recurrence in combination with appropriate-use criteria","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2018.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}